News Focus
News Focus
Post# of 257251
Next 10
Followers 9
Posts 1369
Boards Moderated 0
Alias Born 04/26/2004

Re: 10nisman post# 111373

Thursday, 12/23/2010 12:05:13 PM

Thursday, December 23, 2010 12:05:13 PM

Post# of 257251
So Teva is using the FDA's complete response letter as evidence that MNTA's copaxone can not be approved without clinical trials.

Apparently, the market is buying it.

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now